我要投票 开心人在连锁药店行业中的票数:801
· 外 推 电 报 ·
2026-02-13 17:00:16 星期五

【开心人是哪个国家的品牌?】

开心人是什么牌子?「开心人」是开心人大药房连锁有限公司旗下著名品牌。该品牌发源于江西,由创始人梁永强在2006期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力开心人品牌出海!将品牌入驻外推网,定制开心人品牌推广信息,可以显著提高开心人产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

开心人大药房连锁有限公司在2010年春正式运营上线,运营总部设在北京,在上海和南昌设有运营分部,现有员工一百人。公司团队人员主要由来自各大互联网公司和拥有良好零售经验的人士组成。

我们立志于将我们的电子商务平台-----开心人网上药店打造成中国网络家庭健康商品的第一提供商,现在网站上主营的商品数为一万左右,主要有药品、化妆品、保健品、医疗器械等,我们也在不断扩充商品数。在开心人在线运营的半年时间中,我们已经在发展速度上创造了非常可喜的成绩,在规模上也已经进入行业的前列。

我们希望在创造中国电子商务下一个奇迹的路上,在我们成长的路上有您的加入,我们为您提供良好的工作氛围和很好的成长平台!期待您的加入!
开心人集团规模及发展状况

开心人集团自2002年8月31日开业以来,一直秉承着“品牌创造价值,责任铸就辉煌”的创业理念;“药道即人道、药品即人品”、“卖良心药,做开心人”、“用专业筛选好药、以实惠感恩为民”、“让更多人用得起更多好药”的价值理念;“关注民众、关心民生、降低药价、惠及百姓”的社会责任意识,始终如一地以“药好价低”的社会承诺和经营准则来满足广大群众对医药的消费需求,为改善民生,推进和谐社会建设积极努力。2007年开心人以13.8亿的总销售额名列中国医药连锁前十强,国内连锁店达121家。2010年初花旗银行控股的日本日兴集团国际战略投资(下称"日兴集团")已于近日向开心人注入1亿元人民币,而未来2年内,日兴集团的注资将累计达到3000万~5000万美元。1亿元人民币到位后,开心人将会在今年展开收购整合以及开直营店两大行动,大规模在全国市场布局。将在全国范围内收购部分二、三线城市的药店。目前,其已经启动在福建厦门、新疆、山西、江苏等地的并购计划,目标将主要锁定当地小规模连锁药店,采用全资购买或者控股的方式。除了扩张门店数量外,开心人已经将上市列为其近期目标之一。今年南昌市已把开心人列为重点扶持的拟上市企业,可享受为拟上市企业提供的各种优惠政策。此次日兴集团的投资只是开心人的第一笔融资,而未来3~5年内,开心人还将陆续争取其他企业的风投。八年多来,开心人积累了先进的药店管理经验和大批的药店精英人才。不管是资金、技术、人才、规模,还是管理、经验,开心人的实力都比较雄厚、优势也很明显。

英文翻译:Kaixin pharmacy chain Co., Ltd. was officially launched in the spring of 2010. Its headquarter is located in Beijing. It has operation branches in Shanghai and Nanchang, with 100 employees. The team members of the company are mainly from major Internet companies and people with good retail experience. We are determined to build our e-commerce platform, Kaixinren online drugstore, into the first provider of online family health products in China. Now the number of products on the website is about 10000, mainly including drugs, cosmetics, health products, medical devices, etc. we are also expanding the number of products. In the half year of Kaixin people's online operation, we have made great achievements in the development speed and entered the forefront of the industry in terms of scale. We hope that on the way to create the next miracle of China's e-commerce, you will join us in our growth. We will provide you with a good working atmosphere and a good growth platform! Looking forward to your joining! The scale and development of Kaixinren group since its opening on August 31, 2002, Kaixinren group has been adhering to the entrepreneurial concept of "brand creates value, responsibility creates brilliance;" medicine is humanity, medicine is character "," selling conscience medicine, being Kaixinren "," selecting good medicine with specialty, giving thanks for benefits for the people "and" making more people can use more good medicine " The social responsibility consciousness of "paying attention to the people, caring about the people's livelihood, reducing the drug price and benefiting the people" consistently meets the people's consumption demand for medicine with the social commitment of "good medicine and low price" and the business principle, and makes positive efforts to improve the people's livelihood and promote the construction of a harmonious society. In 2007, Kaixinren ranked among the top ten Chinese pharmaceutical chains with a total sales volume of 1.38 billion, with 121 domestic chains. At the beginning of 2010, Nikko Group International Strategic Investment (hereinafter referred to as "Nikko group") controlled by Citibank has recently injected 100 million yuan into Kaixin people, and in the next two years, Nikko group's investment will reach 30-50 million US dollars in total. After 100 million yuan is in place, Kaixinren will launch two major actions this year, namely acquisition and integration and opening direct stores, to make a large-scale distribution in the national market. Some drugstores in second and third tier cities will be purchased nationwide. At present, it has launched M & A plans in Xiamen, Xinjiang, Shanxi, Jiangsu and other places in Fujian Province, with the goal of mainly targeting local small-scale chain drugstores and adopting wholly-owned purchase or holding. In addition to expanding the number of stores, Kaixin has listed listing as one of its short-term goals. This year, Nanchang City has listed Kaixin people as the key supporting enterprises to be listed, and can enjoy various preferential policies for the enterprises to be listed. The investment of Rixing group is only the first financing of Kaixin group. In the next 3-5 years, Kaixin group will strive for venture capital of other enterprises. Over the past eight years, Kaixin people have accumulated advanced pharmacy management experience and a large number of pharmacy elites. Whether it's capital, technology, talent, scale, management or experience, Kaixin people have strong strength and obvious advantages.

本文链接: https://www.waitui.com/brand/314dd8e28.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

五矿发展:拟购两公司股权,重大资产重组事宜正推进

36氪获悉,五矿发展公告,公司拟通过资产置换、发行股份及支付现金,购买控股股东持有的五矿矿业控股100%股权、鲁中矿业100%股权并募集配套资金,预计构成重大资产重组及关联交易。公司股票于2025年12月30日开市起停牌,2026年1月相关董事会会议审议通过交易相关议案后,股票开市起复牌。截至公告披露日,交易相关的审计、评估、尽职调查等工作正有序推进,交易尚需多项审议和监管机构批准。

2小时前

达梦数据:高级副总经理陈文解除留置

36氪获悉,达梦数据公告,公司于2025年8月22日披露了《关于公司董事兼高级副总经理被立案调查的公告》,公司高级副总经理陈文被湖北省应城市监察委员会立案调查并实施留置措施。近日,公司收到湖北省应城市监察委员会出具的《解除留置通知书》,应城市监察委员会已解除对陈文的留置措施。目前公司生产经营管理情况正常,陈文已能正常履行高级副总经理职责。

2小时前

亚泰集团:拟出售东北证券20.81%股份给长发集团

36氪获悉,亚泰集团公告,公司拟将持有的东北证券20.81%股份出售给长春市城市发展投资控股(集团)有限公司,拟将持有的东北证券9%股份出售给长春市金融控股集团有限公司或其指定的下属子公司。由于公司2023年度、2024年度财务报表被出具了保留意见的审计报告,相关事项的消除尚需确认,且受让方证券公司股东资格尚需进一步沟通,本次重组尚存在重大不确定性。

2小时前

智元发布新一代全尺寸人形机器人远征A3

36氪获悉,2月13日,智元机器人正式发布全新一代全尺寸人形机器人远征A3。据官方介绍,远征A3系列定位于导览导购、文娱商演等高频人机互动场景。硬件层面,远征A3系列具备超拟人全身自由度,手臂末端负载达3kg,TCP末端速度最高可达2m/s,可搭载超拟人、超高自由度灵巧手。能源与续航方面,远征A3首创电池嵌入式躯干设计,搭载外观嵌合双电池系统,满电综合续航最高可达8小时。

2小时前

德国公司Stark在一轮融资中估值超10亿欧元

据媒体周五报道,德国无人机制造初创企业Stark Defence数周前获得投资者新一轮融资,公司整体估值升至10亿欧元以上(12亿美元)。该杂志未透露消息来源,称Peter Thiel旗下的Founders Fund出资数千万欧元,欧洲投资者也参与了本轮融资。(新浪财经)

2小时前

本页详细列出关于开心人的品牌信息,含品牌所属公司介绍,开心人所处行业的品牌地位及优势。
咨询